CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Rocuronium Bromide Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2023-02-15. Latest FDA row update: 2026-10-05.
FDA lists 26 package records, with companies: Baxter Healthcare, Baxter Healthcare Corporation, Eugia US LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals USA, Inc., Hospira, Inc., Hospira, Inc., a Pfizer Company, Meitheal Pharmaceuticals Inc., Meitheal Pharmaceuticals, Inc., Mylan Institutional LLC, Mylan Institutional, a Viatris Company, Piramal Critical Care Inc, Piramal Critical Care Inc., Sagent Pharmaceuticals, Sandoz Inc, Sandoz Inc., XGen Pharmaceuticals DJB, Inc.. Package NDCs: 0143-9250-10, 0143-9251-10, 0409-1403-10, 0409-3189-10, 0409-5160-10, 0409-7037-10, 0781-3220-92, 0781-3220-95, 25021-687-05, 39822-4200-2, 39822-4200-6, 43066-007-10, 43066-013-10, 55150-225-05, 55150-226-10, 63323-426-05, 63323-426-10, 65219-065-05, 65219-442-05, 65219-444-10, 66794-228-41, 66794-229-41, 67457-228-05, 67457-228-10, 71288-700-06, 71288-718-11.
FDA shortage reason: Delay in shipping of the drug; Demand increase for the drug
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Baxter Healthcare | 43066-013-10 | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) | Available | 2026-10-02 |
| Baxter Healthcare | 43066-007-10 | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) | Available | 2026-10-02 |
| Eugia US LLC | 55150-226-10 | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) | Available | 2026-10-02 |
| Eugia US LLC | 55150-225-05 | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) | Available | 2026-10-02 |
| Fresenius Kabi USA, LLC | 63323-426-05 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-426-10 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 65219-065-05 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) | Unavailable | 2026-09-15 |
| Fresenius Kabi USA, LLC | 65219-442-05 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 65219-444-10 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) | Available | 2026-09-15 |
| Hikma Pharmaceuticals USA, Inc. | 0143-9250-10 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Available | 2026-09-18 |
| Hikma Pharmaceuticals USA, Inc. | 0143-9251-10 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Available | 2026-09-18 |
| Hospira, Inc., a Pfizer Company | 0409-5160-10 | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-7037-10 | Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-1403-10 | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-3189-10 | Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) | Available | 2026-09-22 |
| Meitheal Pharmaceuticals, Inc. | 71288-700-06 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) | Available | 2026-08-27 |
| Meitheal Pharmaceuticals, Inc. | 71288-718-11 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) | Available | 2026-08-27 |
| Mylan Institutional, a Viatris Company | 67457-228-05 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) | Available | 2026-10-05 |
| Mylan Institutional, a Viatris Company | 67457-228-10 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) | Available | 2026-10-05 |
| Piramal Critical Care Inc. | 66794-229-41 | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) | Limited Availability | 2026-09-15 |
| Piramal Critical Care Inc. | 66794-228-41 | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) | Available | 2026-09-15 |
| Sagent Pharmaceuticals | 25021-687-05 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) | Available | 2026-09-18 |
| Sandoz Inc. | 0781-3220-92 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) | Available | 2026-09-18 |
| Sandoz Inc. | 0781-3220-95 | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) | Available | 2026-09-18 |
| XGen Pharmaceuticals DJB, Inc. | 39822-4200-6 | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | Available | 2026-09-22 |
| XGen Pharmaceuticals DJB, Inc. | 39822-4200-2 | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | Available | 2026-09-22 |
Source facts
Grouped generic ingredient: Rocuronium Bromide Injection · 26 package records
Therapeutic categories: Anesthesia
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.